Pulm/CC | lover of lungs w/interest in obstructive lung disease & the care of respiratory health in pregnancy | Endeavor NorthShore, University of Chicago Medicine, Michigan Medicine | She/herhttps://bsky.app/profile/sarahgraymd.bsky.socialhttps://bsky.app/profile/sarahgraymd.bsky.social/post/3m2smcw45l227📢 FDA approves Nerandomilast in IPF, first new pulmonary fibrosis drug in over a decade. Slower progression of FVC decline and a (non-significant) trend toward improved mortality (FIBRONEER-IPF, FIBRONEER-ILD) #pulmsky #ILD #IPF https://druganddeviceworld.com/2025/10/02/ers-2025-boehringer-shared-additional-data-for-lung-fibrosis-therapy/10 Oct 2025 02:21 +0000at://did:plc:ovolnhtunfpuyrcsogdzw377/app.bsky.feed.post/3m2smcw45l227https://bsky.app/profile/sarahgraymd.bsky.social/post/3lf767ixyes24Heads up inhaler peeps! Jan 1 GSK joined AZ and BI for the $35 inhaler list, adding: Advair, Anoro, Arnuity, Breo, Incruse, Serevent, Trelegy NOTES -only for commercial insurance or uninsured. NOT Medicare/Medicaid -has to be on formulary, no PA/NDC block Not ideal, but a start details —> #pulmsky08 Jan 2025 02:58 +0000at://did:plc:ovolnhtunfpuyrcsogdzw377/app.bsky.feed.post/3lf767ixyes24https://bsky.app/profile/sarahgraymd.bsky.social/post/3lb76e7z2ok2pLove education about asthma “plus” disorders and other eosinophilic processes. Things like EPGA and ABPA often under recognized in our patients with poor control. Having a basic framework helps increase likelihood of diagnosis and treatment. #pulmsky [contains quote post or other embedded content]18 Nov 2024 05:20 +0000at://did:plc:ovolnhtunfpuyrcsogdzw377/app.bsky.feed.post/3lb76e7z2ok2p